Expression vector of human claudin-10A (CLDN10A). Compatible with lentiviral transduction (3rd generation).
![]() Drawn by SnapGene® software |
|
| Clone info. | Expression vector of human claudin-10A (CLDN10A). Compatible with lentiviral transduction (3rd generation). |
|---|---|
| Comment | BleoR is not applicable for lentivirus transduction, as it is located outside the packaging sequence. |
| Vector backbone | CSII-EF-MCS-IRES2-Venus (RDB04384) (plasmid) |
| Selectable markers | Ampicillin (E. coli). Please note that BleoR marker is not included in the lentivirus produced from this vector. |
| Growth conditions | LB, 37℃ |
| Gene/insert name | human CLDN10 cDNA. |
| Depositor|Developer | Sugimoto, Kotaro | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Ordering forms | Order form [Credit Card Payment MTA, for use for not-for-profit academic purpose [Word Please visit Ordering instruction.[link] |
|---|---|
| Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. (Rahman, A. et al., Int. J.Mol. Sci., 22(7):3774, 2021) For use of the BIOLOGICAL RESOURCE by a for-profit organization or for use of the BIOLOGICAL RESOURCE for for-profit research by not-for-profit organization, the RECIPIENT must obtain a prior written consent from the FUKUSHIMA MEDICAL UNIVERSITY (liaison@fmu.ac.jp). Additional terms and conditions: When publishing the results obtained using the BIOLOGICAL RESOURCE, a citation of literature specified by Dr. Atsushi Miyawaki or an acknowledgement to Dr. Miyawaki is requested. Nagai, T. et al., Nat. Biotechnol. 20: 87-90 (2002). |
| Remarks | Remember that you will be working with samples containing infectious virus. |
[open/close]| 必要書類 | 提供依頼書 提供同意書 (MTA, 非営利学術目的用)[Word 手続きの概要は、「レンチウイルスベクターの提供申し込み」をご覧ください。 |
|---|---|
| MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Rahman, A. et al., Int. J.Mol. Sci., 22(7):3774, 2021)。営利機関の利用もしくは非営利学術機関による営利目的研究利用の場合は、福島県立医科大学 (liaison@fmu.ac.jp) の許可を得ること。 付加的使用条件: When publishing the results obtained using the BIOLOGICAL RESOURCE, a citation of literature specified by Dr. Atsushi Miyawaki or an acknowledgement to Dr. Miyawaki is requested. Nagai, T. et al., Nat. Biotechnol. 20: 87-90 (2002). |
| 備考 | このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 |
| Catalog # | Resource name | Shipping form | Fee |
|---|---|---|---|
| RDB21023 | pCSII-CLDN10A | DNA solution |
Materials & Methods section:
| The pCSII-CLDN10A was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB21023). |
Reference section:
| Rahman, A., Kobayashi, M., Sugimoto, K., Endo, Y., Kojima, M., Furukawa, S., Watanabe, T., Soeda, S., Hashimoto, Y., Fujimori, K., Chiba, H., Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer. Int. J. Mol. Sci. 22 (7): 3774 (2021). PMID 33917356. [PubMed] [Article] [RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
| original | Rahman, A., Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer. Int. J. Mol. Sci. 22 (7): 3774 (2021). PMID 33917356. [PubMed] [Article] [RRC of NBRP] |
|---|
Featured content